Search Weight Loss Topics:




Apr 18

Eli Lilly weight loss injection drug also helps with obstructive sleep apnea, company says – Washington Times

The Eli Lilly weight loss injection Zepbound reduced the intensity of obstructive sleep apnea in patients by nearly two-thirds, the pharmaceutical giant announced Wednesday.

The active ingredient in Zepbound is tirzepatide, and the drug is also marketed as Mounjaro in some markets outside the U.S.

Obstructive sleep apnea involves the restriction of airflow, and obese people are more likely to suffer from it, according to the Centers for Disease Control and Prevention. It impacts 80 million U.S. adults, with more than 20 million suffering from moderate to severe obstructive sleep apnea, the company said.

In clinical trials, patients treated for 52 weeks with tirzepatide who were not using a positive airway pressure (PAP) therapy had an average of 27.4 less airway blockage events per hour and 18.1% loss of weight against the baseline, on average, compared to 4.8 events per hour and 1.3% weight loss for the placebo group, Eli Lilly said.

PAP therapies can include continuous use of the therapy, also known as CPAP. Around 33 million Americans use CPAP machines according to the National Council on Aging.

In the trial for patients also using PAP masks, tirzepatide-using patients had an average of 30.4 fewer airway blockage events per hour and 20.1% weight loss against the baseline on average, compared to six fewer events per hour and 2.3% weight loss against the baseline for the placebo group.

While millions suffer from obstructive sleep apnea, around 85% of cases go undiagnosed and untreated, Eli Lilly said. Zepbound has the potential to be the first pharmaceutical treatment for the underlying disease, Eli Lilly Senior Vice President of Product Development Dr. Jeff Emmick said in a statement.

Read the original:
Eli Lilly weight loss injection drug also helps with obstructive sleep apnea, company says - Washington Times

Related Posts

    Your Full Name

    Your Email

    Your Phone Number

    Select your age (30+ only)

    Select Your US State

    Program Choice

    Confirm over 30 years old

    Yes

    Confirm that you resident in USA

    Yes

    This is a Serious Inquiry

    Yes

    Message:



    matomo tracker